LEWIS, RUSSELL EDWARD
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.560
NA - Nord America 1.318
EU - Europa 973
AF - Africa 501
SA - Sud America 427
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 23
Totale 4.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.053
SG - Singapore 526
BR - Brasile 260
IT - Italia 225
HK - Hong Kong 215
CN - Cina 160
VN - Vietnam 121
PL - Polonia 92
NL - Olanda 44
GB - Regno Unito 42
AT - Austria 39
AR - Argentina 37
IN - India 37
DE - Germania 35
RU - Federazione Russa 30
FI - Finlandia 29
FR - Francia 27
PS - Palestinian Territory 26
GR - Grecia 25
MX - Messico 25
TR - Turchia 25
TH - Thailandia 24
KR - Corea 23
EG - Egitto 22
JO - Giordania 22
SE - Svezia 22
ES - Italia 21
EC - Ecuador 20
JP - Giappone 20
PE - Perù 20
SA - Arabia Saudita 20
ZA - Sudafrica 20
BE - Belgio 19
CA - Canada 19
CI - Costa d'Avorio 19
AE - Emirati Arabi Uniti 18
BJ - Benin 18
MR - Mauritania 18
BF - Burkina Faso 17
BY - Bielorussia 17
GA - Gabon 17
IE - Irlanda 17
KZ - Kazakistan 17
YE - Yemen 17
AO - Angola 16
BG - Bulgaria 16
DJ - Gibuti 16
HN - Honduras 16
ID - Indonesia 16
MK - Macedonia 16
NI - Nicaragua 16
TN - Tunisia 16
TT - Trinidad e Tobago 16
UY - Uruguay 16
YT - Mayotte 16
BA - Bosnia-Erzegovina 15
CH - Svizzera 15
CL - Cile 15
CY - Cipro 15
DZ - Algeria 15
IQ - Iraq 15
KG - Kirghizistan 15
LB - Libano 15
LC - Santa Lucia 15
MZ - Mozambico 15
NO - Norvegia 15
PA - Panama 15
AL - Albania 14
AM - Armenia 14
AZ - Azerbaigian 14
CO - Colombia 14
HR - Croazia 14
LU - Lussemburgo 14
MD - Moldavia 14
MY - Malesia 14
NE - Niger 14
NZ - Nuova Zelanda 14
RO - Romania 14
BB - Barbados 13
CR - Costa Rica 13
GN - Guinea 13
IL - Israele 13
IS - Islanda 13
JM - Giamaica 13
ME - Montenegro 13
MU - Mauritius 13
PH - Filippine 13
PY - Paraguay 13
RE - Reunion 13
SI - Slovenia 13
TZ - Tanzania 13
AD - Andorra 12
BS - Bahamas 12
BW - Botswana 12
CV - Capo Verde 12
DO - Repubblica Dominicana 12
GT - Guatemala 12
IR - Iran 12
KH - Cambogia 12
MA - Marocco 12
Totale 4.307
Salva come PNG Salva come JPEG
Città #
Singapore 293
Hong Kong 203
Ashburn 181
Santa Clara 165
Bytom 51
Ho Chi Minh City 50
Los Angeles 49
Fairfield 47
Boardman 43
Padova 41
Beijing 40
Hefei 30
Milan 30
Buffalo 27
São Paulo 25
Hanoi 24
Houston 23
Amman 21
Chicago 21
New York 20
Cambridge 19
Vienna 19
Abidjan 18
Nuremberg 18
Libreville 17
Nouakchott 17
Cotonou 16
Gdansk 16
Managua 16
Seattle 16
Athens 15
Djibouti 15
Luanda 15
Wilmington 15
Baku 14
Castries 14
Lima 14
Montevideo 14
Conakry 13
Dublin 13
Ouagadougou 13
Woodbridge 13
Yerevan 13
Andorra la Vella 12
Ann Arbor 12
Bangkok 12
Bishkek 12
Helsinki 12
Kampala 12
Lappeenranta 12
Maputo 12
Nassau 12
Panama City 12
Phnom Penh 12
Tokyo 12
Chandler 11
Dakar 11
Kingstown 11
Lusaka 11
Niamey 11
Reykjavik 11
Rome 11
Willemstad 11
Auckland 10
Brasília 10
Cairo 10
Dar es Salaam 10
Gaborone 10
Harare 10
Kingston 10
Leuven 10
Minsk 10
Podgorica 10
Port Moresby 10
Praia 10
Salt Lake City 10
San José 10
Ulan Bator 10
Warsaw 10
Dili 9
Dushanbe 9
Guatemala City 9
Havana 9
Istanbul 9
Kigali 9
Ramallah 9
Sofia 9
Tashkent 9
Tirana 9
Accra 8
Antananarivo 8
Belgrade 8
Bridgetown 8
Cape Town 8
Chennai 8
Hyderabad 8
Johannesburg 8
Kilburn 8
Kuala Lumpur 8
Limassol 8
Totale 2.307
Salva come PNG Salva come JPEG
Nome #
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 167
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 163
Triazole antifungal drug interactions - Practical considerations for excellent prescribing 159
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists 137
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association 136
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good? 135
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective 117
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 112
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis 111
Identification and validation of diagnostic cutoffs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 110
Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 110
Preface - Issue Supplement_4 108
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes 107
Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study 106
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research 105
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 105
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 104
Systemic antifungal agents 104
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer 102
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 99
Preface - Issue Supplement 96
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion 96
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp 93
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria 93
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? 92
Clinical Approach to Infections in the Immunocompromised Host 91
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM 89
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 88
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 86
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia 86
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? 83
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 83
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies 82
Infectious disease consultation for candidaemia 81
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium 81
The lower respiratory tract microbiome of critically ill patients with COVID-19 80
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 78
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 77
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity 75
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis 74
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients 73
Preface 69
Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs 68
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics 67
How long do we need to treat an invasive mold disease in hematology patients? factors influencing duration of therapy and future questions 65
Liposomal amphotericin B-the future 64
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine 62
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions 61
Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections 60
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis 59
Reply to Day et al 58
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections 58
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study 55
Totale 4.920
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.473
article - articoli 15.017
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 456
Totale 30.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 1 31 11 6 4 14
2021/202268 2 14 9 0 1 10 6 5 0 5 7 9
2022/2023117 8 3 1 1 4 3 0 2 2 86 2 5
2023/2024275 5 7 42 26 15 4 19 25 36 29 23 44
2024/20251.188 8 115 26 47 162 97 51 69 122 54 132 305
2025/20263.138 249 308 1.033 1.012 529 7 0 0 0 0 0 0
Totale 4.920